Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021

Rhea-AI Summary

Gossamer Bio (Nasdaq: GOSS) announced it will report its Q2 2021 financial results on August 9, 2021. The live conference call will take place at 4:30 p.m. ET, where management will discuss the results and provide a corporate update. Investors can join the call via domestic at (833) 646-0603 or international at (929) 517-9782. A replay will be available for 30 days on their website, www.gossamerbio.com. Gossamer is focused on developing therapeutics in immunology, inflammation, and oncology.

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that it will report its second quarter 2021 financial results on Monday, August 9, 2021.

In connection with the earnings release, Gossamer’s management team will host a live conference call and webcast at 4:30 p.m. ET on Monday, August 9, 2021, to discuss the Company’s financial results and provide a corporate update.

Conference ID: 1188932
Domestic Dial-in Number: (833) 646-0603
International Dial-in Number: (929) 517-9782
Live Webcast: https://edge.media-server.com/mmc/p/ruj72hwq

A replay of the audio webcast will be available for 30 days on the Investors section of the Company's website, www.gossamerbio.com.

About Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210802005611/en/

FAQ

When will Gossamer Bio release its Q2 2021 financial results?

Gossamer Bio will release its Q2 2021 financial results on August 9, 2021.

What time is the Gossamer Bio conference call?

The conference call to discuss Q2 2021 financial results is scheduled for 4:30 p.m. ET on August 9, 2021.

How can I listen to Gossamer Bio's conference call?

You can listen to Gossamer Bio's conference call by calling (833) 646-0603 for domestic or (929) 517-9782 for international access.

Will there be a replay of Gossamer Bio's conference call?

Yes, a replay will be available for 30 days on the Investors section of Gossamer Bio's website.

What is Gossamer Bio's focus in biopharmaceuticals?

Gossamer Bio focuses on discovering, developing, and commercializing therapeutics in immunology, inflammation, and oncology.